Cargando…

Systematic Analysis of a Xenograft Mice Model for KSHV(+) Primary Effusion Lymphoma (PEL)

Kaposi's sarcoma-associated herpesvirus is the causative agent of primary effusion lymphoma (PEL), which arises preferentially in the setting of infection with human immunodeficiency virus (HIV). Even with standard cytotoxic chemotherapy, PEL continues to cause high mortality rates, requiring t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dai, Lu, Trillo-Tinoco, Jimena, Bai, Lihua, Kang, Baoli, Xu, Zengguang, Wen, Xiaofei, Valle, Luis Del, Qin, Zhiqiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3938717/ https://www.ncbi.nlm.nih.gov/pubmed/24587336 http://dx.doi.org/10.1371/journal.pone.0090349

Ejemplares similares

Classic KSHV/HHV-8-positive Primary Effusion Lymphoma (PEL): A Systematic Review and Meta-Analysis of Case Reports
por: Cozzi, Ilaria, et al.
Publicado: (2022)

Emmprin and KSHV: New partners in viral cancer pathogenesis
por: Dai, Lu, et al.
Publicado: (2013)

Genomic analysis of xCT-regulatory network in KSHV + primary effusion lymphomas
por: Qin, Zhiqiang, et al.
Publicado: (2016)

Molecular mechanisms of activating c-MET in KSHV+ primary effusion lymphoma
por: Lam, Bao Quoc, et al.
Publicado: (2017)

The activation of KSHV lytic cycle blocks autophagy in PEL cells
por: Granato, Marisa, et al.
Publicado: (2015)

Ceramides promote apoptosis for virus-infected lymphoma cells through induction of ceramide synthases and viral lytic gene expression
por: Dai, Lu, et al.
Publicado: (2015)

Role of Interleukin-1 Family Members and Signaling Pathways in KSHV Pathogenesis
por: Barrett, Lindsey, et al.
Publicado: (2020)

Targeting Myc in KSHV-associated primary effusion lymphoma with BET bromodomain inhibitors
por: Tolani, Bhairavi, et al.
Publicado: (2013)

KSHV miRNAs Decrease Expression of Lytic Genes in Latently Infected PEL and Endothelial Cells by Targeting Host Transcription Factors
por: Plaisance-Bonstaff, Karlie, et al.
Publicado: (2014)

Suppression of KSHV lytic replication and primary effusion lymphoma by selective RNF5 inhibition
por: Li, Xiaojuan, et al.
Publicado: (2023)

A role for MALT1 activity in Kaposi's sarcoma-associated herpes virus latency and growth of primary effusion lymphoma
por: Bonsignore, L, et al.
Publicado: (2017)

Extracavitary KSHV-positive Solid Lymphoma: A Large B-cell Lymphoma Within the Spectrum of Primary Effusion Lymphoma
por: Carbone, Antonino, et al.
Publicado: (2013)

A Unique Case of Malignant Pleuropericardial Effusion: HHV-8-Unrelated PEL-Like Lymphoma—A Case Report and Review of the Literature
por: Mohammad, Farhan, et al.
Publicado: (2014)

Hsp90 is a viable therapeutic target in the treatment of KSHV-associated primary effusion lymphoma
por: Nayar, Utthara, et al.
Publicado: (2010)

Transactivation of human endogenous retrovirus K (HERV-K) by KSHV promotes Kaposi’s Sarcoma development
por: Dai, Lu, et al.
Publicado: (2018)

Targeting FoxO proteins induces lytic reactivation of KSHV for treating herpesviral primary effusion lymphoma
por: Lan, Jungang, et al.
Publicado: (2023)

The cellular and KSHV A-to-I RNA editome in primary effusion lymphoma and its role in the viral lifecycle
por: Rajendren, Suba, et al.
Publicado: (2023)

Capsaicin triggers immunogenic PEL cell death, stimulates DCs and reverts PEL-induced immune suppression
por: Granato, Marisa, et al.
Publicado: (2015)

Cross-Talk between NFkB and the PI3-Kinase/AKT Pathway Can Be Targeted in Primary Effusion Lymphoma (PEL) Cell Lines for Efficient Apoptosis
por: Hussain, Azhar R., et al.
Publicado: (2012)

Targeting xCT, a cystine-glutamate transporter induces apoptosis and tumor regression for KSHV/HIV-associated lymphoma
por: Dai, Lu, et al.
Publicado: (2014)

Transcriptomic analysis of KSHV-infected primary oral fibroblasts: The role of interferon-induced genes in the latency of oncogenic virus
por: Dai, Lu, et al.
Publicado: (2016)

CD147 and downstream ADAMTSs promote the tumorigenicity of Kaposi's sarcoma-associated herpesvirus infected endothelial cells
por: Dai, Lu, et al.
Publicado: (2015)

La ciencia de las pel
Publicado: (2009)

Identification of Mubritinib (TAK 165) as an inhibitor of KSHV driven primary effusion lymphoma via disruption of mitochondrial OXPHOS metabolism
por: Calderon, Abram, et al.
Publicado: (2020)

Correction: Cross-Talk between NFkB and the PI3-Kinase/AKT Pathway Can Be Targeted in Primary Effusion Lymphoma (PEL) Cell Lines for Efficient Apoptosis
Publicado: (2014)

Combination of Arsenic and Interferon-α Inhibits Expression of KSHV Latent Transcripts and Synergistically Improves Survival of Mice with Primary Effusion Lymphomas
por: El Hajj, Hiba, et al.
Publicado: (2013)

Draft Genome Sequence of Kocuria palustris PEL
por: Sharma, Gaurav, et al.
Publicado: (2014)

The Zebrafish Xenograft Platform—A Novel Tool for Modeling KSHV-Associated Diseases
por: Pringle, Eric S., et al.
Publicado: (2019)

Targeting KSHV/HHV-8 Latency with COX-2 Selective Inhibitor Nimesulide: A Potential Chemotherapeutic Modality for Primary Effusion Lymphoma
por: George Paul, Arun, et al.
Publicado: (2011)

Capsaicin Induces Apoptosis in KSHV-Positive Primary Effusion Lymphoma by Suppressing ERK and p38 MAPK Signaling and IL-6 Expression
por: Moriguchi, Misato, et al.
Publicado: (2019)

Case of Lymphadenoma, with Relapsing Pyrexia of the Pel-Ebstein Type
por: Henderson, John, et al.
Publicado: (1924)

Cytotoxic Drugs Activate KSHV Lytic Cycle in Latently Infected PEL Cells by Inducing a Moderate ROS Increase Controlled by HSF1, NRF2 and p62/SQSTM1
por: Granato, Marisa, et al.
Publicado: (2018)

Ribonucleotide reductase represents a novel therapeutic target in primary effusion lymphoma
por: Dai, Lu, et al.
Publicado: (2017)

KSHV LANA—The Master Regulator of KSHV Latency
por: Uppal, Timsy, et al.
Publicado: (2014)

Upregulation of xCT by KSHV-Encoded microRNAs Facilitates KSHV Dissemination and Persistence in an Environment of Oxidative Stress
por: Qin, Zhiqiang, et al.
Publicado: (2010)

Biosynthesis of the Pseudomonas aeruginosa Extracellular Polysaccharides, Alginate, Pel, and Psl
por: Franklin, Michael J., et al.
Publicado: (2011)

Reagent Controlled Glycosylations for the Assembly of Well-Defined Pel Oligosaccharides
por: Wang, Liming, et al.
Publicado: (2020)

Fever of Unknown Origin: The Workup and Diagnosis of Pel-Ebstein Fever
por: Khanna, Prachi, et al.
Publicado: (2022)

Contribution of Pseudomonas aeruginosa Exopolysaccharides Pel and Psl to Wound Infections
por: Fleming, Derek, et al.
Publicado: (2022)

KSHV vFLIP Is Essential for the Survival of Infected Lymphoma Cells
por: Guasparri, Ilaria, et al.
Publicado: (2004)

Cannot write session to /tmp/vufind_sessions/sess_m5aru5ubdqur5eqgkr8sp481fv